Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton London Docklands Riverside Hotel

Sep 19, 2018 8:00 AM - Sep 20, 2018 5:00 PM

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Global Clinical Trials Transparency Conference

Session 5: Summary Protocol and Results Information: & EudraCT

Session Chair(s)

Matthias  Zerm, PhD

Matthias Zerm, PhD

Lead Expert, Clinical Trial Disclosure and R&D Processes


Are you prepared to posting results in both registries? How do you ensure consistency across registries considering differences in data fields, process (quality review versus purely automated validation) and timing? This session will address procedural aspects, will give insights around the quality control review at and provide an outlook on how information contained in clinical trial registries may become more aligned and more meaningful for patients.


Thomas  Wicks, MBA

Managing Submissions to Global Registries: Thomas Wicks, MBA

Head of Transparency Operations

Citeline, United States

Heather  Dobbins, PhD

Results Submission “Success”: An Update: Heather Dobbins, PhD Lead Results Analyst, NCBI/NLM

National Institutes of Health (NIH), United States

Smita  Shukla

Improving GSK’s first time acceptance record for Results submissions on : Smita Shukla

Director Clinical Disclosure Reporting

GSK, United States

Munther  Baara, MS

Transcelerate Initiative to Improve Data Quality in Clinical Trial Registries: Munther Baara, MS

Vice President, Product Strategy and Innovation

EDETEK, Inc. , United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.